Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration

NCT02083666 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Transient adverse events observed

Conditions

Healthy

Interventions

DRUG: SOBI002
DRUG: Placebo

Sponsor

Swedish Orphan Biovitrum

Collaborators

[object Object]